The Comprehensive Sickle Cell Center at The Children's Hospital of Philadelphia (CHOP) is in its fourth year of operation. In the past four years, we have made much progress in all the major components of the Center. Although much has been learned about sickle cell disease at all levels, effective therapy which takes advantage of this knowledge is still elusive. Even if such therapy were to become available soon, there is a need for accurate diagnosis and counseling; diagnosis and management of serious complications such as stroke; and education of those affected by the disease and those who manage it. These broad needs are addressed in this application. The main objective of our proposal is to seek new information about sickle cell disease and to translate this information into treatment programs which will improve the health and quality of life of sickle cell patients. The laboratory research includes studies on the expression of fetal hemoglobin, interaction of Hb S and mutagenized globin chains, mRNA structure and stability, experiments with transgenic mice, and in red cell deformability using image analysis system. Clinical projects address nutrition, energy metabolism and growth, the development of cerebrovascular disease, and a limited multi-center trial of hydroxyurea in children with sickle cell disease. In our diagnosis and counseling projects, we will develop methods for specific identification of the common beta-gene mutations, and another project determines if a newborn screening program for sickle cell disease can be designed and implemented in West Africa. Educational projects include an extension of the computer-based education on sickle cell disease, a program to improve educational outcome for young children with sickle cell disease and employment opportunities for adolescent patients. A third educational project takes educational programs developed and evaluated at this Center into regional programs of professional education about sickle cell disease. These projects are supported by a central administrative core, a clinical research unit, and a laboratory core which includes a state-of-the-art nucleic acid and protein chemistry laboratory service. In addition to investigators from the Division of Hematology of CHOP, investigators from other Divisions of CHOP and from other departments of the University of Pennsylvania are participants in the Center. We continue our collaborative arrangement with one investigator from Thomas Jefferson University Hospital. The Center proposes to maintain its strong links with the community.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL038632-07
Application #
2218957
Study Section
Special Emphasis Panel (SRC (SH))
Project Start
1988-04-04
Project End
1998-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ballas, Samir K; Connes, Philippe; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia (2018) Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and ?-thalassemia. Eur J Haematol 101:798-803
Kwiatkowski, Janet L; Zimmerman, Robert A; Pollock, Avrum N et al. (2009) Silent infarcts in young children with sickle cell disease. Br J Haematol 146:300-5
Adachi, Kazuhiko; Ding, Min; Asakura, Toshio et al. (2009) Relationship between beta4 hydrogen bond and beta6 hydrophobic interactions during aggregate, fiber or crystal formation in oversaturated solutions of hemoglobin A and S. Arch Biochem Biophys 481:137-44
Kiryu, Shigeru; Sundaram, Tessa; Kubo, Shigeto et al. (2008) MRI assessment of lung parenchymal motion in normal mice and transgenic mice with sickle cell disease. J Magn Reson Imaging 27:49-56
Niebanck, Alison E; Pollock, Avrum N; Smith-Whitley, Kim et al. (2007) Headache in children with sickle cell disease: prevalence and associated factors. J Pediatr 151:67-72, 72.e1
Uematsu, Hidemasa; Takahashi, Masaya; Hatabu, Hiroto et al. (2007) Changes in T1 and T2 observed in brain magnetic resonance imaging with delivery of high concentrations of oxygen. J Comput Assist Tomogr 31:662-5
Obata, Kazuo; Mattiello, Julian; Asakura, Kenji et al. (2006) Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes. Am J Hematol 81:26-35
Akbar, Mohammed G K; Tamura, Yutaka; Ding, Min et al. (2006) Inhibition of hemoglobin S polymerization in vitro by a novel 15-mer EF-helix beta73 histidine-containing peptide. Biochemistry 45:8358-67
Adachi, Kazuhiko; Ding, Min; Surrey, Saul et al. (2006) The Hb A variant (beta73 Asp-->Leu) disrupts Hb S polymerization by a novel mechanism. J Mol Biol 362:528-38
Asakura, Toshio; Asakura, Kenji; Obata, Kazuo et al. (2005) Blood samples collected under venous oxygen pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: constancy of the percentage of sickled cells in individual patients during steady state. Am J Hematol 80:249-56

Showing the most recent 10 out of 140 publications